ANIP FY 2010 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2010 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M+96.7% YoY

Gross Profit

$2M89.1% margin

Operating Income

-$44M-1762.5% margin

Net Income

-$46M-1867.1% margin

EPS (Diluted)

$-25.23

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$992,757

Balance Sheet

Total Assets

$45M

Total Liabilities

$26M

Stockholders' Equity

$19M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+96.7%
Gross Profit	$2M	$1M	+75.3%
Operating Income	-$44M	-$38M	-13.5%
Net Income	-$46M	-$48M	+2.8%